Holiday celebrations in Torrington maintain their small-town charm, with Christmas parades featuring local children and ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Traditional caching fails to stop "thundering ...

Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Several lots of a generic ADHD medication used by millions are under recall because users may not be getting the full benefit. Sun Pharmaceutical Industries issued the voluntary, nationwide recall for ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...

The Food and Drug Administration said it will take steps to speed up the process of developing generic versions of complex biological drugs, in a bid to increase cheaper competition for expensive ...

A new investigative report released by Senators Kirsten Gillibrand (D-NY) and Rick Scott (R-FL), ranking member and chairman of the US Senate Special Committee on Aging, respectively, details the ...

The FDA has approved a second generic version of oral mifepristone, used to terminate pregnancy, after determining it is identical to the branded drug. The FDA Thursday approved generic mifepristone ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a second generic form of mifepristone. HHS is reportedly reviewing mifepristone after state ...

Oct 2 (Reuters) - The U.S. Food and Drug Administration has approved Evita Solution's generic version of the abortion drug, mifepristone, the regulator said. The FDA said in a letter dated September ...